{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:32:16Z","timestamp":1793817136135,"version":"4.6.1"},"reference-count":179,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006730","name":"Ministry of Education and Research, Romania","doi-asserted-by":"publisher","award":["HG 118\/2023"],"award-info":[{"award-number":["HG 118\/2023"]}],"id":[{"id":"10.13039\/501100006730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006012","name":"Christian Doppler Forschungsgesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["CD10271603"],"award-info":[{"award-number":["CD10271603"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jhep.2024.06.016","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T13:03:52Z","timestamp":1718888632000},"page":"895-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":356,"title":["Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2313-7881","authenticated-orcid":false,"given":"Vlad","family":"Taru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-2527","authenticated-orcid":false,"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-3671","authenticated-orcid":false,"given":"Wajahat","family":"Mehal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-3583","authenticated-orcid":false,"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.06.016_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2024.06.016_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Gracia-Sancho","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A\u00a0morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis","volume":"56","author":"D\u2019Ambrosio","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib6","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.cgh.2022.11.033","article-title":"Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis","volume":"21","author":"Hofer","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/apt.12721","article-title":"Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients","volume":"39","author":"D\u2019Amico","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.06.016_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib9","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2021.01.018","article-title":"New clinical and pathophysiological perspectives defining the trajectory of cirrhosis","volume":"75","author":"Jalan","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib11","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2024.06.016_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-0157-z","article-title":"Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human","volume":"6","author":"Zhao","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.jhep.2024.06.016_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/eji.201847485","article-title":"Innate immune cells orchestrate the repair of sterile injury in the liver and beyond","volume":"49","author":"Hossain","year":"2019","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2024.06.016_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2024.06.016_bib19","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhep.2024.06.016_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cel"},{"key":"10.1016\/j.jhep.2024.06.016_bib22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of interferon-\u03b3 inducing factor mediated by interleukin-1\u03b2 converting enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jhep.2024.06.016_bib23","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2024.06.016_bib24","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/jimmunol\/202.7.1913","article-title":"Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages","volume":"202","author":"Fink","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2007.12.040","article-title":"Active caspase-1 is a regulator of unconventional protein secretion","volume":"132","author":"Keller","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2024.06.016_bib26","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1128\/MCB.01468-07","article-title":"ATP binding by monarch-1\/NLRP12 is critical for its inhibitory function","volume":"28","author":"Ye","year":"2008","journal-title":"Mol Cel Biol"},{"key":"10.1016\/j.jhep.2024.06.016_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-065X.2011.01053.x","article-title":"The PYHIN protein family as mediators of host defenses","volume":"243","author":"Schattgen","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2024.06.016_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ni.1702","article-title":"An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome","volume":"10","author":"B\u00fcrckst\u00fcmmer","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib29","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","article-title":"A\u00a0360\u00b0 view of the inflammasome: mechanisms of activation, cell death, and diseases","volume":"186","author":"Barnett","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2024.06.016_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imr.12884","article-title":"The NLRP1 and CARD8 inflammasomes","volume":"297","author":"Taabazuing","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2024.06.016_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib32","doi-asserted-by":"crossref","first-page":"36560","DOI":"10.1074\/jbc.M607594200","article-title":"Critical role for Cryopyrin\/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA","volume":"281","author":"Kanneganti","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2024.06.016_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature07965","article-title":"Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence","volume":"459","author":"Gross","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2","volume":"9","author":"Halle","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A\u00a0role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib37","doi-asserted-by":"crossref","first-page":"16955","DOI":"10.1074\/jbc.M112.358705","article-title":"Role of inflammasomes in host defense against citrobacter rodentium infection","volume":"287","author":"Liu","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2024.06.016_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.chom.2014.07.001","article-title":"Epithelium-intrinsic NAIP\/NLRC4 inflammasome drives infected enterocyte expulsion to restrict salmonella replication in the intestinal mucosa","volume":"16","author":"Sellin","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2024.06.016_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ni1346","article-title":"Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1\u03b2 in salmonella-infected macrophages","volume":"7","author":"Franchi","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ni1344","article-title":"Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1\u03b2 via Ipaf","volume":"7","author":"Miao","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chom.2010.11.007","article-title":"Differential requirement for caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing","volume":"8","author":"Broz","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2024.06.016_bib43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ni.1864","article-title":"The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses","volume":"11","author":"Rathinam","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib44","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cell.2011.04.022","article-title":"NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis","volume":"145","author":"Elinav","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2024.06.016_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib46","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.1240248","article-title":"Noncanonical inflammasome activation by intracellular LPS independent of TLR4","volume":"341","author":"Kayagaki","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jhep.2024.06.016_bib47","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.1240988","article-title":"Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock","volume":"341","author":"Hagar","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jhep.2024.06.016_bib48","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib49","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1002\/eji.201545655","article-title":"NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5","volume":"45","author":"Baker","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib50","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/eji.201545772","article-title":"Caspase-11 activates a canonical NLRP3 inflammasome by promoting K+ efflux","volume":"45","author":"R\u00fchl","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib51","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/eji.201545523","article-title":"Caspase-4 mediates non-canonical activation of the NLRP3 inflammasome in human myeloid cells","volume":"45","author":"Schmid-Burgk","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41590-021-00869-6","article-title":"Inflammasomes and adaptive immune responses","volume":"22","author":"Deets","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2018.12.024","article-title":"Inflammasome activation and Th17 responses","volume":"107","author":"Deng","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib55","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2024.06.016_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1007990","article-title":"Caspase-11-dependent IL-1\u03b1 release boosts Th17 immunity against Paracoccidioides brasiliensis","volume":"15","author":"Ketelut-Carneiro","year":"2019","journal-title":"Plos Pathog"},{"key":"10.1016\/j.jhep.2024.06.016_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ni.2195","article-title":"NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8\u00a0+ T cells","volume":"13","author":"Kupz","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib58","doi-asserted-by":"crossref","first-page":"12419","DOI":"10.1073\/pnas.1019041108","article-title":"Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity","volume":"108","author":"Sauer","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2024.06.016_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib60","volume":"vol. 592","author":"Dudek","year":"2021"},{"key":"10.1016\/j.jhep.2024.06.016_bib61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jceh.2021.08.027","article-title":"Gut barrier and microbiota in cirrhosis","volume":"12","author":"Philips","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib62","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.06.016_bib63","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cmi.13079","article-title":"Canonical and noncanonical inflammasomes in intestinal epithelial cells","volume":"21","author":"Winsor","year":"2019","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.jhep.2024.06.016_bib66","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1152\/ajpgi.90223.2008","article-title":"Inflammasome-mediated regulation of hepatic stellate cells","volume":"296","author":"Watanabe","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2024.06.016_bib67","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.7150\/thno.29620","article-title":"p66Shc contributes to liver fibrosis through the regulation of mitochondrial reactive oxygen species","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jhep.2024.06.016_bib68","article-title":"Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma","volume":"10","author":"Liu","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jhep.2024.06.016_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-78688-2","article-title":"NKT cells promote both type 1 and type 2 inflammatory responses in a mouse model of liver fibrosis","volume":"10","author":"Nilsson","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2024.06.016_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar7754","article-title":"Type 3 cytokines IL-17A and IL-22 drive TGF-\u03b2-dependent liver fibrosis","volume":"3","author":"Fabre","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib71","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3389\/fimmu.2020.01149","article-title":"Macrophage sphingosine 1-phosphate receptor 2 blockade attenuates liver inflammation and fibrogenesis triggered by NLRP3 inflammasome","volume":"11","author":"Hou","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib72","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212413","article-title":"MyD88 in macrophages enhances liver fibrosis by activation of NLRP3 inflammasome in HSCs","volume":"22","author":"Ge","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2024.06.016_bib74","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0040-1708540","article-title":"The NLRP3 inflammasome in alcoholic and nonalcoholic steatohepatitis","volume":"40","author":"Knorr","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2024.06.016_bib75","article-title":"Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD","volume":"7","author":"Pierantonelli","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2024.06.016_bib76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib77","first-page":"751","article-title":"Cell-specific deletion of NLRP3 inflammasome identifies myeloid cells as key drivers of liver inflammation and fibrosis in murine steatohepatitis","volume":"14","author":"Kaufmann","year":"2022","journal-title":"CMGH"},{"key":"10.1016\/j.jhep.2024.06.016_bib78","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.32776","article-title":"Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis","volume":"77","author":"Knorr","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib79","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4049\/jimmunol.159.3.1451","article-title":"Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages","volume":"159","author":"Ferrari","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0234038","article-title":"Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis","volume":"15","author":"Baeza-Raja","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2024.06.016_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2020.07.023","article-title":"P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells","volume":"333","author":"Jiang","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jhep.2024.06.016_bib82","article-title":"Deficiency of the purinergic receptor 2X7 attenuates nonalcoholic steatohepatitis induced by high-fat diet: possible role of the NLRP3 inflammasome","volume":"2017","author":"Blasetti Fantauzzi","year":"2017","journal-title":"Oxid Med Cel Longev"},{"key":"10.1016\/j.jhep.2024.06.016_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061346","article-title":"Deletion of perilipin 5 protects against hepatic injury in nonalcoholic fatty liver disease via missing inflammasome activation","volume":"9","author":"Asimakopoulou","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2024.06.016_bib84","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep4.1057","article-title":"The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis","volume":"1","author":"Wettstein","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.06.016_bib85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"MacEyka","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib86","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1136\/gutjnl-2020-322509","article-title":"Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis","volume":"70","author":"Koh","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.06.016_bib87","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jcmgh.2021.12.002","article-title":"Sphingosine 1-phosphate receptor 4 promotes nonalcoholic steatohepatitis by activating NLRP3 inflammasome","volume":"13","author":"Hong","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2015.248","article-title":"ER stress induces NLRP3 inflammasome activation and hepatocyte death","volume":"6","author":"Lebeaupin","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhep.2024.06.016_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2021-325013","article-title":"NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression","author":"Latif","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.06.016_bib90","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2024.06.016_bib91","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1189\/jlb.3AB1214-590R","article-title":"Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease","volume":"98","author":"Petrasek","year":"2015","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jhep.2024.06.016_bib92","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jhep.2014.12.027","article-title":"Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1\u03b2 in mice","volume":"62","author":"Cui","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib93","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A\u00a0double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020182","article-title":"NLRP6 inflammasome modulates disease progression in a chronic-plus-binge mouse model of alcoholic liver disease","volume":"11","author":"Mainz","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2024.06.016_bib95","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib96","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/TP.0b013e318259d38e","article-title":"Endoplasmic reticulum stress modulates liver inflammatory immune response in the pathogenesis of liver ischemia and reperfusion injury","volume":"94","author":"Liu","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2024.06.016_bib97","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib98","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","article-title":"TXNIP: a key protein in the cellular stress response pathway and a potential therapeutic target","volume":"55","author":"Choi","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhep.2024.06.016_bib99","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/gutjnl-2017-315123","article-title":"Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression","volume":"68","author":"Heo","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.06.016_bib100","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/hep.28680","article-title":"Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease","volume":"64","author":"Bukong","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib101","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jhep.2015.06.013","article-title":"Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice","volume":"63","author":"Iracheta-Vellve","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib102","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.06.016_bib104","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0024-3205(86)90554-0","article-title":"Serum interleukin-1 (IL-1) activity in alcoholic hepatitis","volume":"39","author":"McClain","year":"1986","journal-title":"Life Sci"},{"key":"10.1016\/j.jhep.2024.06.016_bib105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.yexmp.2014.08.006","article-title":"The inflammasome in alcoholic hepatitis: its relationship with Mallory-Denk body formation","volume":"97","author":"Peng","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jhep.2024.06.016_bib106","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/hep.29645","article-title":"Pyroptosis by caspase11\/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients","volume":"67","author":"Khanova","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/HEP.0000000000000298","article-title":"Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation","volume":"78","author":"de Carvalho Ribeiro","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jhep.2014.08.027","article-title":"Absent in melanoma 2 triggers a heightened inflammasome response in ascitic fluid macrophages of patients with cirrhosis","volume":"62","author":"Lozano-Ruiz","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib109","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/gutjnl-2019-320170","article-title":"Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation","volume":"70","author":"Monteiro","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.06.016_bib110","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.06.016_bib111","article-title":"The NLRP3 inflammasome mediates liver failure by activating procaspase-1 and pro-IL-1 \u03b2 and regulating downstream CD40-CD40L signaling","volume":"49","author":"Li","year":"2021","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.jhep.2024.06.016_bib112","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molimm.2020.01.011","article-title":"NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF","volume":"120","author":"Jia","year":"2020","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib113","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-0039-1687851","article-title":"Macrophages as key players during adipose tissue-liver crosstalk in nonalcoholic fatty liver disease","volume":"39","author":"Korf","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2024.06.016_bib114","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cmet.2008.08.015","article-title":"Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals","volume":"8","author":"Patsouris","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2024.06.016_bib115","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00125-016-3904-9","article-title":"Adipose tissue macrophages: going off track during obesity","volume":"59","author":"Boutens","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2024.06.016_bib116","first-page":"1","article-title":"Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice","volume":"8","author":"Stanton","year":"2011","journal-title":"J\u00a0Inflamm"},{"key":"10.1016\/j.jhep.2024.06.016_bib117","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib118","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s00125-013-3023-9","article-title":"Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue","volume":"56","author":"Esser","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2024.06.016_bib119","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/db10-0266","article-title":"Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1\u03b2 transcription in human adipose tissue","volume":"60","author":"Koenen","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2024.06.016_bib120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2024.06.016_bib121","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2337\/db13-1511","article-title":"T\u00a0cell+derived IL-22 amplifies IL-1\u03b2+driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes","volume":"63","author":"Dalmas","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2024.06.016_bib122","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2010.11.011","article-title":"The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity","volume":"12","author":"Stienstra","year":"2010","journal-title":"Cel Metab"},{"key":"10.1016\/j.jhep.2024.06.016_bib123","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41423-019-0296-z","article-title":"NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling","volume":"18","author":"Unamuno","year":"2021","journal-title":"Cel Mol Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib124","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/JOE-18-0598","article-title":"Adipose tissue browning in mice and humans","volume":"241","author":"Herz","year":"2019","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.jhep.2024.06.016_bib125","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00180.2019","article-title":"NLRP3 inflammasome mediates white adipose tissue browning after burn","volume":"317","author":"Vinaik","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2024.06.016_bib126","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1194\/jlr.M079665","article-title":"Brown adipose tissue whitening leads to brown adipocyte death and adipose tissue inflammation","volume":"59","author":"Kotzbeck","year":"2018","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2024.06.016_bib127","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2020.01.011","article-title":"Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure","volume":"73","author":"Engelmann","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00042737-200303000-00011","article-title":"Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis","volume":"15","author":"Manigold","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib129","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/jhep.2003.50180","article-title":"Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis","volume":"37","author":"Riordan","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib131","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.jhep.2024.06.016_bib132","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/hepr.12883","article-title":"Hepatic nucleotide binding oligomerization domain-like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease","volume":"47","author":"Mitsuyoshi","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2024.06.016_bib133","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2017.11.040","article-title":"Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice","volume":"68","author":"Xu","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib134","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/liv.12575","article-title":"Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease","volume":"35","author":"Voican","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.06.016_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1215333","article-title":"NLRP3: a new therapeutic target in alcoholic liver disease","volume":"14","author":"Brahadeeswaran","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib136","first-page":"1","article-title":"The NLRP3 inflammasome in non-alcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhep.2024.06.016_bib137","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","article-title":"IL-1 pathways in inflammation and human diseases","volume":"6","author":"Gabay","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib138","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.32478","article-title":"IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis","author":"Szabo","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib139","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/liv.12570","article-title":"The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis","volume":"35","author":"Barreyro","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2024.06.016_bib140","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.23167","article-title":"Pan-caspase inhibitor VX-166\u00a0reduces fibrosis in an animal model of nonalcoholic steatohepatitis","volume":"50","author":"Witek","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib141","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jhep.2019.12.010","article-title":"Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension","volume":"72","author":"Garcia-Tsao","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib142","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2020.09.029","article-title":"Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis","volume":"74","author":"Frenette","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib143","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ijo.2016.74","article-title":"Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-\/-.Leiden mice","volume":"40","author":"Morrison","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/j.jhep.2024.06.016_bib144","first-page":"1","article-title":"A\u00a0long way to go: caspase inhibitors in clinical use","volume":"12","author":"Dhani","year":"2021","journal-title":"Cel Death Dis"},{"key":"10.1016\/j.jhep.2024.06.016_bib145","first-page":"1148","article-title":"Gasdermin D inhibitor necrosulfonamide alleviates lipopolysaccharide\/D-galactosamine-induced acute liver failure in mice","volume":"10","author":"Wu","year":"2022","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib146","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123294","article-title":"ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model","volume":"5","author":"Schuster-Gaul","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhep.2024.06.016_bib147","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib148","first-page":"8A","article-title":"Selonsertib in combination with prednisolone for the treatment of severe alcoholic hepatitis: a phase 2 randomized controlled trial","volume":"68","author":"Mathurin","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib149","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A\u00a0small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2024.06.016_bib150","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib151","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.12.019","article-title":"Nuclear receptor subfamily 1 group D member 1 regulates circadian activity of NLRP3 inflammasome to reduce the severity of fulminant hepatitis in mice","volume":"154","author":"Pourcet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.06.016_bib152","first-page":"1","article-title":"MCC950 ameliorates acute liver injury through modulating macrophage polarization and myeloid-derived suppressor cells function","volume":"8","author":"Yan","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhep.2024.06.016_bib153","doi-asserted-by":"crossref","first-page":"E817","DOI":"10.1152\/ajpendo.00427.2019","article-title":"Androgen aggravates liver fibrosis by activation of NLRP3 inflammasome in CCl4-induced liver injury mouse model","volume":"318","author":"Ma","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jhep.2024.06.016_bib154","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.intimp.2019.02.016","article-title":"The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice","volume":"70","author":"Qu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jhep.2024.06.016_bib155","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.31494","article-title":"Bidirectional role of NLRP3 during acute and chronic cholestatic liver injury","volume":"73","author":"Frissen","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.06.016_bib156","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jhep.2024.06.016_bib157","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1007\/s11695-020-04571-8","article-title":"Sleeve gastroplasty combined with the NLRP3 inflammasome inhibitor CY-09 reduces body weight, improves insulin resistance and alleviates hepatic steatosis in mouse model","volume":"30","author":"Sun","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.jhep.2024.06.016_bib158","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbrc.2020.11.009","article-title":"NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice","volume":"534","author":"Wang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2024.06.016_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-22022-5","article-title":"Significance of elevated serum and hepatic NOD-like receptor pyrin domain containing 3 (NLRP3) in hepatitis C virus-related liver disease","volume":"12","author":"Aggan","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2024.06.016_bib160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.dld.2008.09.021","article-title":"Pro-inflammatory Interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment","volume":"41","author":"Roth","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2024.06.016_bib161","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1128\/JVI.01962-13","article-title":"Hepatitis C virus induces interleukin-1\u03b2 (IL-1\u03b2)\/IL-18 in circulatory and resident liver macrophages","volume":"87","author":"Shrivastava","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhep.2024.06.016_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121911","article-title":"Enhanced inflammasome-mediated inflammation and impaired autophagy in peripheral blood mononuclear cells is associated with non-alcoholic fatty liver disease severity","volume":"329","author":"Saha","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.jhep.2024.06.016_bib163","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1572-0241.2004.40009.x","article-title":"Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients","volume":"99","author":"Ribeiro","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2024.06.016_bib164","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2010.09.006","article-title":"Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers","volume":"138","author":"Singh","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-015-0360-y","article-title":"Expression of AIM2 is correlated with increased inflammation in chronic hepatitis B patients","volume":"12","author":"Han","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2024.06.016_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-021-05719-2","article-title":"IL-1 Signal Inhibition in Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis","volume":"22","author":"Vergis","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.jhep.2024.06.016_bib167","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2024.06.016_bib168","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1152\/ajpgi.00366.2013","article-title":"Inhibition of Toll-like receptor 4 suppresses liver injury induced by biliary obstruction and subsequent intraportal lipopolysaccharide injection","volume":"306","author":"Oya","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2024.06.016_bib169","doi-asserted-by":"crossref","first-page":"36617","DOI":"10.1074\/jbc.M112.407130","article-title":"Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation","volume":"287","author":"Juliana","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2024.06.016_bib170","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"NF-kB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib171","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20132486","article-title":"The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation","volume":"211","author":"Rodgers","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2024.06.016_bib172","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib173","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib174","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","article-title":"Gasdermin D pore structure reveals preferential release of mature interleukin-1","volume":"593","author":"Xia","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2024.06.016_bib176","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ni.2237","article-title":"Regulation of inflammasome signaling","volume":"13","author":"Rathinam","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib177","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4049\/jimmunol.1403100","article-title":"Cutting edge: inflammasome activation in primary human macrophages is dependent on flagellin","volume":"195","author":"Kortmann","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib178","doi-asserted-by":"crossref","first-page":"631","DOI":"10.4049\/jimmunol.2000382","article-title":"Salmonella flagellin activates NAIP\/NLRC4 and canonical NLRP3 inflammasomes in human macrophages","volume":"206","author":"Gram","year":"2021","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2024.06.016_bib179","doi-asserted-by":"crossref","first-page":"28309","DOI":"10.1074\/jbc.C100250200","article-title":"Identification of ipaf, a human caspase-1-activating protein related to apaf-1","volume":"276","author":"Poyet","year":"2001","journal-title":"J\u00a0Biol Chem"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824023225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824023225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:58:47Z","timestamp":1773457127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824023225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":179,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0168827824023225"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.06.016","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}